Trials Sponsors Conditions Drugs Pricing

Conditions

Inpatients Who Generate at Least Two Rothman Index Scores

Outcome Measures

Primary Outcomes (1)

Mortality and/or discharge to hospice care
A composite outcome of mortality and discharge to hospice care as determined by medical record review. Either will be adequate to meet this endpoint.
Assessed from the date of randomization to the date of the first documented death or discharge to hospice during patient's current hospitalization, up to 365 days

Secondary Outcomes (6)

ICU transfer
Assessed from the date of randomization to the date of first documented ICU transfer during patient's current hospitalization, up to 365 days
Length of stay
Assessed as the number of days from the date of randomization to the first documented discharge, up to 365 days
Incurred hospital costs
Assessed as costs accrued from the date of randomization to the patient's first documented discharge, up to 365 days
Readmission
30 days post-randomization
30 day mortality
30 days post-randomization
+1 more secondary outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

Patients in the control arm will have a Rothman Index calculated but this will not be visible to providers.

Intervention

EXPERIMENTAL

Patients in the intervention arm will have a Rothman Index calculated and will be visible to providers. Providers will be given a set of clinician-specific recommended-use protocols that they will be encouraged to follow based on the RI thresholds achieved by patients.

Device: Rothman Index

Interventions

Rothman IndexDevice

The Rothman Index score will be calculated and visible to providers. Providers will be encouraged to follow a set of recommended-use protocols in response to different levels of the RI threshold.

Intervention

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Adults inpatients greater than or equal to 18 years of age
Admitted to any inpatient unit at two study sites within the Yale New Haven Health System

Sponsors & Collaborators

PeraHealth
Type not reportedcollaborator
Yale University
Otherlead

Study Sites (2)

Greenwich Hospital

Greenwich, Connecticut, 06830, United States

Lawrence + Memorial Hospital

New London, Connecticut, 06320, United States

Study Officials

Francis P Wilson, MD MSCE
Yale University
PRINCIPAL INVESTIGATOR

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: SUPPORTIVE CARE
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

May 14, 2020

First Posted

May 27, 2020

Study Start

November 2021

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Stopped

Assessing Efficacy of the Rothman Index

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Study Arms (2)

Usual Care

Intervention

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Study Arms (2)

Usual Care

Intervention

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations